Fsn-1006

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameFsn-1006

Drug Alias NameFsn-1006Fsn-1006h

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanizedBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionHeparin-binding EGF-like growth factor inhibitors

TargetsHeparin-binding EGF-like growth factor

Therapy Area/IndicationsColorectal NeoplasmsBreast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Clinical)

Highest Status in ChinaN/A

Originator CompaniesFusion Antibodies

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesFusion Antibodies

Active IndicationsN/A

Inactive IndicationsColorectal NeoplasmsBreast Neoplasms

Other Information

ATC CodeN/A